Helius Medical Technologies Partners with Lovell Government Services to Expand PoNS Therapy’s Reach
DENVER, Colo., Apr 03, 2024 (247marketnews.com)- Helius Medical Technologies, Inc. (NASDAQ:HSDT) reported, this morning, that it partnered with Lovell Government Services, an SBA-certified Service-Disabled Veteran Owned Small Business and an approved supplier to the U.S. Department of Veterans Affairs and Department of Defense, to make Helius Medical’s Portable Neuromodulation Stimulator device available to federal healthcare systems.
“Through their Multiple Sclerosis Centers of Excellence, the VA is dedicated to maximizing the quality of life for veterans suffering from MS, and we are thrilled to partner with Lovell to expand the reach of our innovative PoNS device. In a study of real-world results, after 14 weeks of PoNS Therapy, 100% of MS patients experienced a clinically meaningful improvement in gait. More than 28,000 cases of MS are reported to the VA annually, making PoNS a potential game changer for veterans and their families,” said Dane Andreeff, President and Chief Executive Officer of Helius.
“As the largest integrated healthcare system in the U.S., the VA provides services to veterans with MS from the time of diagnosis through the rest of their lives. Veterans have given their best to our country and should have access to the most innovative and effective resources available. Lovell is proud to introduce this important product to the VA and other federal healthcare providers,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services.
“Recently, Helius highlighted the real-life story of Kevin Byrne, a retired U.S. veteran who’s been suffering from MS since 1999. Gait difficulties had taken away his most valued treasure, quality adventures with his 13-year-old daughter, but PoNS Therapy helped him improve his walking by increasing speed, endurance, and distance. After treatment with PoNS, he was able to take his daughter to New York City, where they enjoyed walking the streets and seeing Broadway shows, experiences he thought were lost forever. While clinical results have demonstrated the effectiveness of PoNS Therapy, it’s firsthand accounts like Captain Byrne’s that are the most gratifying,” concluded Andreeff.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (HSDT)
- Dealmaking Drives the Tape: These Stocks Are Heating Up into the Close
- Capital Meets Conviction: VENU, HSDT, GLUE, and IHT Show Investors the Money
- MoBot alert highlights: NASDAQ: HSDT, NASDAQ: RCEL, NYSE: GPUS, NYSE: ATCH, NASDAQ: HYFT (09/15/25 06:00 AM)
- MoBot alert highlights: NYSE: ATCH, NASDAQ: HSDT, NASDAQ: HYFT, NASDAQ: HAIN, NASDAQ: BTBD (09/15/25 05:00 AM)
- Today’s Top Performers: MoBot’s Market Review 09/15/25 04:00 AM